德国对新冠肺炎医药产品的国家援助：欧盟团结的风险。

IF 0.6 Q2 LAW

EUROPEAN JOURNAL OF HEALTH LAW Pub Date : 2022-03-09 DOI:10.1163/15718093-bja10061

Kristine Plank

{"title":"德国对新冠肺炎医药产品的国家援助：欧盟团结的风险。","authors":"Kristine Plank","doi":"10.1163/15718093-bja10061","DOIUrl":null,"url":null,"abstract":"To respond to the need for a vaccine against and a treatment for Covid-19, the German Federal Government (German government) used various economic incentives to promote pharmaceutical and biotechnological (biotech) research and development (R&D) as well as manufacturing. More specifically, it decided to subsidise several German companies working in this field. Such domestic measures might, however, present a challenge to European state aid law. It is against this backdrop that this article discusses the compatibility of the payments made with the new 'crisis-born' European legal framework for state aid. Furthermore, the article offers some critical comments on the aid's effects on solidarity and cohesion in the European Union (EU) and the proposals put forward for expanding the EU's health policy competencies.","PeriodicalId":43934,"journal":{"name":"EUROPEAN JOURNAL OF HEALTH LAW","volume":"29 1 1","pages":"53-78"},"PeriodicalIF":0.6000,"publicationDate":"2022-03-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":"{\"title\":\"German State Aid for Covid-19 Medicinal Products: A Risk for Solidarity in the European Union.\",\"authors\":\"Kristine Plank\",\"doi\":\"10.1163/15718093-bja10061\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"To respond to the need for a vaccine against and a treatment for Covid-19, the German Federal Government (German government) used various economic incentives to promote pharmaceutical and biotechnological (biotech) research and development (R&D) as well as manufacturing. More specifically, it decided to subsidise several German companies working in this field. Such domestic measures might, however, present a challenge to European state aid law. It is against this backdrop that this article discusses the compatibility of the payments made with the new 'crisis-born' European legal framework for state aid. Furthermore, the article offers some critical comments on the aid's effects on solidarity and cohesion in the European Union (EU) and the proposals put forward for expanding the EU's health policy competencies.\",\"PeriodicalId\":43934,\"journal\":{\"name\":\"EUROPEAN JOURNAL OF HEALTH LAW\",\"volume\":\"29 1 1\",\"pages\":\"53-78\"},\"PeriodicalIF\":0.6000,\"publicationDate\":\"2022-03-09\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"EUROPEAN JOURNAL OF HEALTH LAW\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1163/15718093-bja10061\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"LAW\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"EUROPEAN JOURNAL OF HEALTH LAW","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1163/15718093-bja10061","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"LAW","Score":null,"Total":0}

引用次数: 2

摘要

为了应对新冠肺炎疫苗和治疗的需求，德国联邦政府（德国政府）利用各种经济激励措施促进制药和生物技术（生物技术）研发（研发）以及制造业。更具体地说，它决定补贴在这一领域工作的几家德国公司。然而，这种国内措施可能会对欧洲国家援助法构成挑战。正是在这种背景下，本文讨论了支付款项与新的“危机产生”的欧洲国家援助法律框架的兼容性。此外，文章还对援助对欧盟（EU）团结和凝聚力的影响以及为扩大欧盟卫生政策能力提出的建议提出了一些批评意见。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

German State Aid for Covid-19 Medicinal Products: A Risk for Solidarity in the European Union.

To respond to the need for a vaccine against and a treatment for Covid-19, the German Federal Government (German government) used various economic incentives to promote pharmaceutical and biotechnological (biotech) research and development (R&D) as well as manufacturing. More specifically, it decided to subsidise several German companies working in this field. Such domestic measures might, however, present a challenge to European state aid law. It is against this backdrop that this article discusses the compatibility of the payments made with the new 'crisis-born' European legal framework for state aid. Furthermore, the article offers some critical comments on the aid's effects on solidarity and cohesion in the European Union (EU) and the proposals put forward for expanding the EU's health policy competencies.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

EUROPEAN JOURNAL OF HEALTH LAW LAW-

CiteScore

0.90

自引率

0.00%

发文量

期刊介绍： The European Journal of Jewish Studies (EJJS) is the Journal of the European Association for Jewish Studies (EAJS). Its main purpose is to publish high-quality research articles, essays and shorter contributions on all aspects of Jewish Studies. Submissions are all double blind peer-reviewed. Additionally, EJJS seeks to inform its readers on current developments in Jewish Studies: it carries comprehensive review-essays on specific topics, trends and debated questions, as well as regular book-reviews. A further section carries reports on conferences, symposia, and descriptions of research projects in every area of Jewish Studies.